| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2a7f6a961f374583010c275d7806ca0 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 |
| filingDate |
2005-05-12^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_32c3012be61d93889ca5c5655bbf4431
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e5ff5358847f5295351389d64f5aa3a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_20e601e66377076369c70245590e0456 |
| publicationDate |
2016-12-28^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
HU-E028336-T2 |
| titleOfInvention |
Use of 24-Nor-UDCA for the treatment of cholestatic liver disease |
| abstract |
The present invention relates to nor-ursodeoxycholic acid and/or pharmaceutically acceptable salts and esters thereof for use in the treatment and/or the prevention of hepatocellular carcinoma and cholangiocarcinoma. |
| priorityDate |
2005-05-12^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |